Literature DB >> 38408

Selective stimulation of central alpha-autoreceptors following treatment with alpha-methyldopa and FLA 136.

N E Andén.   

Abstract

1. The accumulation of normetanephrine in the rat brain induced by the monoamine oxidase inhibitor nialamide was inhibited following alpha-methyldopa and 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazole (FLA 136). It was not changed following alpha-methylmetatyrosine despite a greater disappearance of noradrenaline than after alpha-methyldopa. The alpha-adrenoreceptor blocking agent yohimbine increased the nialamide-induced accumulation of normetanephrine and completely antagonized the actions of alpha-methyldopa and FLA 136, indicating that the effects of the two drugs are due to stimulation of alpha-adrenoreceptors. 2. The flexor reflex activity of spinalized rats was not influenced by alpha-methyldopa and alpha-methylmetatyrosine at the doses used in the biochemical experiments, as previously found for FLA 136, indicating no stimulation of classical, postsynaptic, central alpha-adrenoreceptors. 3. The biochemical effects of alpha-methyldopa and FLA 136 might be caused by stimulation of alpha-autoreceptors on the cell bodies and the nerve terminals of noradrenaline neurons. A similar mechanism might be involved in the hypotension reported by other investigators following these drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38408     DOI: 10.1007/bf00507112

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline.

Authors:  N E Andén; M Grabowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-07       Impact factor: 3.000

2.  A method for the determination of normetanephrine in brain.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Physiol Scand       Date:  1962-01

3.  The preparation and antihypertensive activity of 4-amino-3-(2,6-dichlorobenzylidenehydrazino)-1,2,4-triazole and some related compounds.

Authors:  H E Eriksson; L G Florvall
Journal:  Acta Pharm Suec       Date:  1976

4.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

Review 5.  Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines.

Authors:  J Axelrod
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

6.  Normetanephrine accumulation in the spinal cord due to nerve impulse activity.

Authors:  N E Andén; B Börjesson; T Magnusson
Journal:  Eur J Pharmacol       Date:  1968-10       Impact factor: 4.432

7.  alpha-Methylnoradrenaline induced hypotension and bradycardia after administration into the area of the nucleus tractus solitarii.

Authors:  F P Nijkamp; W De Jong
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

8.  Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.

Authors:  H Schmitt; S Fénard
Journal:  Arzneimittelforschung       Date:  1973-01

9.  Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa.

Authors:  A Heise; G Kroneberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

10.  Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine.

Authors:  P Bolme; H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; M Goldstein
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

View more
  1 in total

1.  Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.

Authors:  M Carlsson; A Svensson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.